Costa Rica Chikungunya Outbreak Prompts Updated CDC Travel Notice

Chikungunya cases first tied to Costa Rica’s Pacific beach communities are now being detected further inland, as the U.S. Centers for Disease Control and Prevention (CDC) refreshes its travel notice and urges visitors to practice enhanced precautions.

Level 2 Notice Highlights Expanding Risk

The CDC recently renewed a Level 2 Travel Health Notice for Costa Rica, advising travelers to “practice enhanced precautions” in response to a chikungunya outbreak centered in Guanacaste Province. The advisory, last reviewed in mid-July 2026, points to ongoing transmission in the popular Playa Langosta area and other coastal communities along the north Pacific shoreline.

While initial reports focused on beach destinations that draw large numbers of international visitors, public health surveillance summaries now indicate that chikungunya infections are being confirmed away from the immediate coast. Cases have been reported in residents and travelers who spent time in inland towns connected to Guanacaste’s tourism corridor, suggesting that virus-carrying mosquitoes and infected individuals are moving beyond beachfront neighborhoods.

Regional surveillance updates from health agencies in the Americas note that Costa Rica has recorded a small but growing number of confirmed chikungunya cases in 2026, including locally acquired infections. Earlier in the year, most confirmed cases were traced to coastal exposure, but recent data show that some patients reported travel across multiple cantons, including highland hubs commonly used as staging points for trips to both the Pacific and Caribbean coasts.

Although the overall number of cases in Costa Rica remains modest compared with outbreaks seen in parts of the Caribbean and South America, the pattern of spread inland is drawing attention because it broadens the geographic areas in which visitors may encounter infected mosquitoes. The refreshed CDC notice reflects this evolving picture by emphasizing that risk is not confined to one town or resort area.

How Chikungunya Spreads Across Regions

Chikungunya is transmitted by Aedes mosquitoes, primarily Aedes aegypti and Aedes albopictus, which thrive in tropical and subtropical climates. These mosquitoes are widely established across Costa Rica, from coastal lowlands to many populated inland valleys, giving the virus ample opportunity to move once it is introduced into a community.

Travel patterns can accelerate this process. When infected travelers visit additional regions within Costa Rica during the first week of illness, they can be bitten by local mosquitoes that then spread the virus to new people. Research on arbovirus transmission in the country has shown that outbreaks of mosquito-borne diseases often spread between cantons along major transport routes, with tourism and commerce helping to link coastal and inland areas.

Climate conditions also influence how far and how fast chikungunya can travel. Warm temperatures, periodic heavy rainfall, and urban water storage practices create breeding sites in both resort zones and inland towns. Even locations perceived as cooler or more elevated can support Aedes mosquitoes if there is standing water in containers, gutters, or ornamental plantings near homes and lodgings.

Because chikungunya shares mosquito vectors with dengue and Zika, public health specialists in Central America track these viruses together when assessing transmission risk. Past experience in Costa Rica has shown that once a virus becomes established along one coast, subsequent movement into inland transit hubs and secondary tourist destinations is common, especially during the rainy season.

CDC Advice for Travelers to Costa Rica

The updated CDC notice advises travelers to Costa Rica to focus on preventing mosquito bites, particularly in Guanacaste Province and surrounding areas, but also in inland regions linked to current travel routes. Recommendations include using insect repellent with active ingredients such as DEET, picaridin, IR3535, or oil of lemon eucalyptus, wearing long sleeves and long pants when possible, and choosing accommodations with air conditioning or well-fitted screens.

Publicly available guidance also stresses the importance of reducing mosquito exposure during peak biting times, which often occur during the daytime and early evening for Aedes species. Travelers are encouraged to use bed nets in settings where screens and air conditioning are unreliable and to check rooms for standing water in items such as buckets, planters, and open containers, which can be removed or emptied.

The CDC has recently introduced recommendations on the use of a chikungunya vaccine for some U.S. travelers. Current guidance suggests that vaccination may be considered for people aged 12 years and older who plan extended stays or repeated travel to areas with either current chikungunya outbreaks or elevated risk of transmission. Costa Rica, now included in a specific travel health notice, falls within the group of destinations where clinicians may discuss vaccine options with higher-risk travelers.

People more likely to develop severe disease, including adults with certain chronic medical conditions and pregnant travelers late in pregnancy, are advised to consult a travel health specialist well before departure. Public information notes that those at increased risk might consider postponing nonessential travel to locations with sustained chikungunya outbreaks, especially during peak mosquito season.

Symptoms, Medical Care, and Implications for Itineraries

According to CDC educational materials, chikungunya typically begins with sudden fever and intense joint pain, often accompanied by headache, muscle aches, fatigue, and rash. Symptoms usually appear three to seven days after a bite from an infected mosquito. While most people recover within a week, some experience debilitating joint pain that can last for months.

Travelers returning from Costa Rica who develop fever or severe joint pain are advised in public guidance to seek prompt medical evaluation and to inform clinicians of their recent travel history. Because chikungunya symptoms can overlap with dengue and other infections, laboratory testing is often needed to confirm the diagnosis. There is currently no specific antiviral treatment; care focuses on rest, fluids, and medications to relieve pain and fever.

For visitors planning itineraries that combine beach stays in Guanacaste with inland volcanoes, cloud forests, or capital-area sightseeing, the inland spread of chikungunya means that mosquito precautions should be applied consistently across all stops, not only at the coast. Even short overnight stays in transit hubs can present some level of exposure if mosquitoes are present and local transmission is occurring.

Travel health specialists recommend building flexibility into plans in case illness develops during or shortly after a trip. Public advice emphasizes that anyone who feels unwell should avoid further mosquito exposure for at least a week after symptoms start, which may involve staying indoors in air-conditioned or well-screened rooms and continuing to use repellent. This step helps reduce the chance of onward transmission in both Costa Rica and travelers’ home communities.

What the Updated Notice Means for Tourism

The renewed CDC notice comes at a time when Costa Rica’s tourism sector is experiencing strong demand for nature, wellness, and adventure travel. Industry observers note that the country has long managed seasonal surges of dengue and other mosquito-borne illnesses without deterring most visitors, but chikungunya’s painful symptoms and the appearance of cases inland are likely to draw closer scrutiny from health-conscious travelers.

Travel advisories at Level 2 typically do not recommend canceling or avoiding trips; instead, they highlight the need for additional safeguards. For Costa Rica, this means that tour operators, hotels, and vacation rental hosts may face increased questions from guests about mosquito control practices, availability of air-conditioned rooms, and access to medical care in more remote areas.

Publicly available statements from Costa Rican tourism bodies and health officials in recent years have emphasized the country’s experience in monitoring mosquito-borne diseases and implementing vector control campaigns. Local authorities routinely conduct fumigation drives, promote community clean-up efforts, and share public messages on eliminating standing water, steps that can help suppress Aedes mosquito populations when sustained over time.

Travel analysts suggest that the refreshed chikungunya notice, combined with the inland detection of cases, will likely encourage travelers to plan more deliberately, seeking pre-travel medical advice, updating routine vaccinations, and budgeting time and resources for comprehensive mosquito protection. For now, Costa Rica remains open to visitors, with health agencies and international partners closely tracking how the chikungunya situation evolves through the current rainy season and beyond.